DOI: 10.1055/s-00000005

Aktuelle Rheumatologie

References

Machado P, Miller A, herbelin L et al.
LB002 safety and tolerability of arimoclomol in patients with sporadic inclusion body myositis: a randomised, double-blind, placebo-contolled, phase IIa proof-of-concept trial.

Ann Rheum Dis 2013;
72: 164

Download Bibliographical Data

Search in:
Access: